22 Dec 2015 --- Kappa Bioscience has expanded its intellectual property portfolio with the award of a European patent on the synthesis of a nature-identical vitamin K2 MK-7 molecule. This patent represents both a scientific and commercial breakthrough by positioning this exciting and essential vitamin for mass-market adoption.